Skip to main content
. Author manuscript; available in PMC: 2014 Nov 25.
Published in final edited form as: Eur J Pharm Biopharm. 2013 Dec 19;86(3):514–523. doi: 10.1016/j.ejpb.2013.12.009

Table 3.

Composition of gemcitabine and gemcitabine prodrugs in Caco-2 cell uptake studies without Gly-Pro (mean ± SD, n = 3).

Compound Cytosine (%) Gemcitabine (%) Prodrug (%)
Gemcitabine 50 50
5′-L-Phenylalanyl- gemcitabine 0 18 82
5′-D-Phenylalanyl- gemcitabine 0 31 69
5′-L-Valyl-gemcitabine 0 15 85
5′-D-Valyl-gemcitabine 0 10 90